Note №35WHAT TO CHECK
Some patients ask the clinic to open the product box in front of them. We cannot tell you how common that is and we are not going to pretend otherwise — but we can tell you whether it accomplishes anything. Korean law prints a fixed list of items on that box, and two of them can be checked against a public government database before the needle comes out. We read the statutes in the original on 24 August 2026.
The request is simple enough: don’t bring it pre-loaded, open it here. It is easy to dismiss as theatre. It is not quite theatre — but what it proves is narrower than people think, and the useful part happens after the box is open, not when it is.
Filler and toxin are not the same kind of thing
This is where most patients go wrong before they even look at the packaging. In Korea, a dermal filler and a botulinum toxin sit under two different Acts, with two different labelling regimes and two different public databases.
A filler is a medical device. It falls under the Medical Devices Act, and what must be printed on its container or outer packaging is set out in Article 20.
A toxin is a prescription drug. It falls under the Pharmaceutical Affairs Act, and its labelling requirements are in Article 56.
So “is it genuine?” is really two questions with two different answers, and the thing you are supposed to read differs between them. We have written before about how the same device carries different names in different markets — this is the same problem one layer down, at the level of the box in the room.
What the law requires on a device box
Article 20 of the Medical Devices Act requires the manufacturer or importer to print the following on the container or outer packaging:
- the trade name and address of the manufacturer or importer;
- for an imported product, the country of manufacture and the manufacturer’s name;
- the licence, certification or notification number, and the name of the item — product name, item name, model name;
- the manufacturing number and the year and month of manufacture — or the use-by date in its place;
- the weight or packaging unit;
- the words “medical device”;
- where the product is single-use: the words “single use” and “do not reuse”;
- the medical device standard code set by the Minister of Food and Drug Safety in consultation with the Minister of Health and Welfare.
Two of those are checkable by a patient standing in the room: the licence number and the standard code. The rest are context.
What the law requires on a drug vial
Article 56(1) of the Pharmaceutical Affairs Act requires the licence holder or importer to print on the container or packaging, among other things:
- the trade name and address of the licence holder or importer — including the manufacturing site where production was contracted out;
- the product name;
- the manufacturing number and the expiry or use-by date;
- the weight, volume or count;
- the name of every ingredient on the licence, the quantity of active ingredient, and the quantity of preservative;
- the words “prescription drug” or “over-the-counter drug”;
- the items required in the package insert — which may be replaced by a barcode pointing to that content.
The phrase to look for is 전문의약품 — prescription drug. A botulinum toxin sold for cosmetic use in Korea carries it. Its absence on something being drawn into a syringe is a question worth asking out loud.
What opening the box actually proves
Be clear about the limits, because this is where the ritual oversells itself.
It does prove that the packaging existed, that it was sealed until that moment, and — more usefully — that you had a chance to read what is printed on it before it was discarded. A product already drawn up in a syringe gives you nothing to read.
It does not prove what is inside. It does not prove the product was stored at the right temperature between the importer and that room. It does not prove the dilution. A box tells you what the product claims to be; it cannot tell you what happened to it.
So the value of the request is not the theatre of the seal breaking. It is that an unopened box is a document, and you only get to read it once.
The two lookups
Both are free, public, and run by the Ministry of Food and Drug Safety.
For a device, the ministry’s medical device information portal at emedi.mfds.go.kr carries item licence information. The licence number and the standard code printed on the box are what you search against. If a product is being presented as an approved filler, the licence should exist and the product name should match.
For a drug, 의약품안전나라 at nedrug.mfds.go.kr carries item licence information, and — worth knowing — a published record of administrative dispositions against companies. Both were live when we checked on 24 August 2026.
Neither lookup requires an account. We did not verify how much of either portal is available in English; assume you may need a translation app in the waiting room.
What the law does to a clinic that gets this wrong
The prohibitions are not vague, and they are not administrative slaps.
Devices. Article 26(1) of the Medical Devices Act says nobody may sell, lend, give or use a medical device that has not been licensed, certified or notified — nor store or display one for those purposes. Article 51(1)2 makes a violation punishable by up to five years’ imprisonment or a fine of up to ₩50 million, and Article 51(2) allows both to be imposed together.
Drugs. Article 62 of the Pharmaceutical Affairs Act prohibits selling — or storing, importing or displaying for sale — a drug whose ingredients or quantities differ from what was licensed, along with drugs that are contaminated, decomposed, or packaged so as to mislead about how they are used.
A clinic using an unlicensed device is not committing a paperwork offence. It is committing a crime with a five-year ceiling.
What this note does not claim
We are not claiming that counterfeit product is common in Korean clinics, or rare. We did not measure it, and we found no figure we were willing to print. We are not claiming that any particular group of patients asks for the box more often than another — that belongs to anecdote, not to this site. We did not verify how the standard code is issued or how quickly a new product appears in the portals, whether either portal is usable in English, or what a clinic is obliged to do if a patient asks. Nothing here is medical or legal advice, and no clinic is named.
What we did was read what the two Acts require to be printed, and confirm that the two government databases exist and are open to the public.
Common questions
Is a clinic required to open the box in front of me?
We found no provision requiring it. The labelling duties in Article 20 of the Medical Devices Act and Article 56 of the Pharmaceutical Affairs Act fall on manufacturers and importers, not on the treating clinic, and they govern what is printed — not when the packaging is opened. Asking is a request, not a right we could locate in the statutes.
What is the single most useful thing printed on the box?
For a device, the licence, certification or notification number, because it can be searched against the ministry’s public database. For a drug, the manufacturing number and expiry date together with the words 전문의약품.
Does “single use” on a device box mean anything for me?
Article 20(7) of the Medical Devices Act requires single-use devices to carry both “single use” and “do not reuse” on the packaging. If those words are on a box whose contents are being used across more than one patient, that is a discrepancy you can see with your own eyes.
What happens to a clinic that uses an unlicensed device?
Use of an unlicensed, uncertified or unnotified medical device is prohibited by Article 26(1) of the Medical Devices Act, and Article 51(1)2 sets the penalty at up to five years’ imprisonment or a fine of up to ₩50 million, which may be imposed together.
Sources
All provisions read in the original on the National Law Information Center (국가법령정보센터), 24 August 2026. Both ministry portals accessed the same day.
- Medical Devices Act (의료기기법), Article 20 (용기 등의 기재사항), Article 26(1) (일반행위의 금지), Article 51 (벌칙) — https://www.law.go.kr/법령/의료기기법
- Pharmaceutical Affairs Act (약사법), Article 56(1) (의약품 용기 등의 기재 사항), Article 62 (제조 등의 금지), Article 47-3 (의약품관리종합정보센터) — https://www.law.go.kr/법령/약사법
- Ministry of Food and Drug Safety, medical device information portal (의료기기안심책방) — https://emedi.mfds.go.kr
- Ministry of Food and Drug Safety, 의약품안전나라 — https://nedrug.mfds.go.kr
The Clinic Notes — verified, source-cited information on cosmetic medicine in South Korea. We accept no payments or benefits from clinics, hospitals, doctors, or referral agencies.